All Stories

  1. Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease

    Article • PLOS One, May 2021, PLOS

    Dr Wah Kheong Chan

  2. Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

    Article • United European Gastroenterology Journal, June 2016, SAGE Publications

    Dr Wah Kheong Chan

  3. Non‐alcoholic fatty liver disease in diabetics – prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

    Article • Journal of Gastroenterology and Hepatology, July 2013, Wiley

    Dr Wah Kheong Chan